Abstract
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system that results in destruction of the myelin sheath wrapped around the axons and eventual axon degeneration. The disease is pathologically heterogeneous; however, perhaps its most frustrating aspect is the lack of efficient regenerative response for remyelination. Current treatment strategies are based on anti-inflammatory or immunomodulatory medications that have the potential to reduce the numbers of newly evolving lesions. However, therapies are still required that can repair already damaged myelin for which current treatments are not effective. A prerequisite for the development of such new treatments is understanding the reasons for insufficient endogenous repair. This review briefly summarizes the currently suggested causes of remyelination failure in MS and possible solutions.
Similar content being viewed by others
Abbreviations
- MS:
-
Multiple sclerosis
- CNS:
-
Central nervous system
- PL:
-
Proteolipid protein,
- CXCL1:
-
Chemokine (C-X-C motif) ligand 1
- sema3A:
-
Semaphorins 3A
- LINGO-1:
-
Leucine-rich repeat and immunoglobulin domain containing NOGO receptor interacting protein 1
- RXRs:
-
Retinoid X receptors
- EAE:
-
Experimental autoimmune encephalomyelitis
- NgR1 complex:
-
Nogo-66 receptor complex
References
Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306(5704):2111–2115. doi:10.1126/science.1103709
Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nature Medicine 11(9):966–972. doi:10.1038/nm1279
Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJ, Altmann F, Lubec G, Kotter MR (2009) Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain : A Journal of Neurology 132(Pt 2):465–481. doi:10.1093/brain/awn334
Bin JM, Rajasekharan S, Kuhlmann T, Hanes I, Marcal N, Han D, Rodrigues SP, Leong SY, Newcombe J, Antel JP, Kennedy TE (2013) Full-length and fragmented netrin-1 in multiple sclerosis plaques are inhibitors of oligodendrocyte precursor cell migration. The American Journal of Pathology 183(3):673–680. doi:10.1016/j.ajpath.2013.06.004
Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu Q, Raz E (2008) Control of chemokine-guided cell migration by ligand sequestration. Cell 132(3):463–473
Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathologica 125(6):841–859. doi:10.1007/s00401-013-1112-y
Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116(2):167–179
Casaccia-Bonnefil P, Liu A (2003) Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. Journal of Neuroscience Research 72(1):1–11. doi:10.1002/jnr.10565
Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B, Lubetzki C (2000) Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proceedings of the National Academy of Sciences of the United States of America 97(13):7585–7590. doi:10.1073/pnas.100076197
Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C (2002) Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain : A Journal of Neurology 125(Pt 9):1972–1979
Chen ZJ, Ughrin Y, Levine JM (2002) Inhibition of axon growth by oligodendrocyte precursor cells. Molecular and Cellular Neurosciences 20(1):125–139. doi:10.1006/mcne.2002.1102
Cohen RI, Rottkamp DM, Maric D, Barker JL, Hudson LD (2003) A role for semaphorins and neuropilins in oligodendrocyte guidance. Journal of Neurochemistry 85(5):1262–1278
Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335 (6075):1503-1506.
Cunnea P, Mhaille AN, McQuaid S, Farrell M, McMahon J, FitzGerald U (2011) Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 17 (7):808-818. doi:10.1177/1352458511399114
Czopka T, Von Holst A, Schmidt G, Ffrench-Constant C, Faissner A (2009) Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia 57(16):1790–1801. doi:10.1002/glia.20891
Dai J, Bercury KK, Ahrendsen JT, Macklin WB (2015) Olig1 function is required for oligodendrocyte differentiation in the mouse brain. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 35(10):4386–4402. doi:10.1523/jneurosci.4962-14.2015
Dawson MR, Polito A, Levine JM, Reynolds R (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Molecular and Cellular Neurosciences 24(2):476–488
Dehghan S, Hesaraki M, Soleimani M, Mirnajafi-Zadeh J, Fathollahi Y, Javan M (2016) Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice. Neuroscience 318:178–189. doi:10.1016/j.neuroscience.2016.01.028
Dehghan S, Javan M, Pourabdolhossein F, Mirnajafi-Zadeh J, Baharvand H (2012) Basic fibroblast growth factor potentiates myelin repair following induction of experimental demyelination in adult mouse optic chiasm and nerves. Journal of Molecular Neuroscience : MN 48(1):77–85. doi:10.1007/s12031-012-9777-6
Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK (2004) Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 148(1–2):116–126. doi:10.1016/j.jneuroim.2003.11.010
Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes & Development 23(13):1571–1585. doi:10.1101/gad.1806309
Feigenson K, Reid M, See J, Crenshaw EB 3rd, Grinspan JB (2009) Wnt signaling is sufficient to perturb oligodendrocyte maturation. Molecular and cellular neurosciences 42(3):255–265. doi:10.1016/j.mcn.2009.07.010
Fernandez-Enright F, Andrews JL, Newell KA, Pantelis C, Huang XF (2014) Novel implications of Lingo-1 and its signaling partners in schizophrenia. Translational Psychiatry 4 (1):e348-. doi:10.1038/tp.2013.121
Fewou SN, Ramakrishnan H, Bussow H, Gieselmann V, Eckhardt M (2007) Down-regulation of polysialic acid is required for efficient myelin formation. The Journal of Biological Chemistry 282(22):16700–16711. doi:10.1074/jbc.M610797200
Franceschini I, Vitry S, Padilla F, Casanova P, Tham TN, Fukuda M, Rougon G, Durbec P, Dubois-Dalcq M (2004) Migrating and myelinating potential of neural precursors engineered to overexpress PSA-NCAM. Molecular and Cellular Neurosciences 27(2):151–162. doi:10.1016/j.mcn.2004.05.006
Fuss B, Wintergerst ES, Bartsch U, Schachner M (1993) Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160/180: a modular structure similar to tenascin. The Journal of Cell Biology 120(5):1237–1249
Fyffe-Maricich SL, Karlo JC, Landreth GE, Miller RH (2011) The ERK2 Mitogen-Activated Protein Kinase Regulates the Timing of Oligodendrocyte Differentiation. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 31(3):843–850. doi:10.1523/jneurosci.3239-10.2011
Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H (2006) International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev 58(4):760–772
Ghasemi-Kasman M, Hajikaram M, Baharvand H, Javan M (2015) MicroRNA-mediated in vitro and in vivo direct conversion of astrocytes to neuroblasts. PloS one 10(6):e0127878. doi:10.1371/journal.pone.0127878
Ghasemi-Kasman M, Zare L, Baharvand H, Javan M (2016) In vivo conversion of astrocytes to myelinating cells by miR-302/367 and Valproate to enhance myelin repair J TERM In press
Gutowski NJ, Newcombe J, Cuzner ML (1999) Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling. Neuropathology and Applied Neurobiology 25(3):207–214
Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451(7182):1076–1081. doi:10.1038/nature06559
Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 20(6):2218–2228
Hosking MP, Tirotta E, Ransohoff RM, Lane TE (2010) CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS One 5(6):e11340. doi:10.1371/journal.pone.0011340
Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Baron-Van Evercooren A, Chambon P, Ffrench-Constant C, Franklin RJ (2011a) Retinoid X receptor gamma signaling accelerates CNS remyelination. Nature Neuroscience 14(1):45–53. doi:10.1038/nn.2702
Huang JK, Jarjour AA, Oumesmar BN, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Baron-Van Evercooren A, Chambon P, Ffrench-Constant C, Franklin RJM (2011b) Retinoid X receptor gamma signaling accelerates CNS remyelination. Nature Neuroscience 14(1):45–53. doi:10.1038/nn.2702
Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O (2007) Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson’s disease models. Proceedings of the National Academy of Sciences of the United States of America 104(36):14430–14435. doi:10.1073/pnas.0700901104
Ishii A, Fyffe-Maricich SL, Furusho M, Miller RH, Bansal R (2012) ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 32(26):8855–8864. doi:10.1523/jneurosci.0137-12.2012
Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A (2009) Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochemistry International 54(3–4):192–198. doi:10.1016/j.neuint.2008.10.011
John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nature Medicine 8(10):1115–1121. doi:10.1038/nm781
Karimi-Abdolrezaee S, Schut D, Wang J, Fehlings MG (2012) Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS One 7(5):e37589. doi:10.1371/journal.pone.0037589
Keough MB, Rogers JA, Zhang P, Jensen SK, Stephenson EL, Chen T, Hurlbert MG, Lau LW, Rawji KS, Plemel JR, Koch M, Ling CC, Yong VW (2016) An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination. Nature Communications 7:11312. doi:10.1038/ncomms11312
Kiernan BW, Gotz B, Faissner A, ffrench-Constant C (1996) Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Molecular and Cellular Neurosciences 7(4):322–335. doi:10.1006/mcne.1996.0024
Kippert A, Fitzner D, Helenius J, Simons M (2009) Actomyosin contractility controls cell surface area of oligodendrocytes. BMC Cell Biology 10:71. doi:10.1186/1471-2121-10-71
Kotter MR, Li WW, Zhao C, Franklin RJ (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 26(1):328–332. doi:10.1523/jneurosci.2615-05.2006
Lariosa-Willingham KD, Rosler ES, Tung JS, Dugas JC, Collins TL, Leonoudakis D (2016) A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells. BMC Research Notes. doi:10.1186/s13104-016-2220-2
Lau LW, Cua R, Keough MB, Haylock-Jacobs S, Yong VW (2013) Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nature Reviews Neuroscience 14(10):722–729. doi:10.1038/nrn3550
Lau LW, Keough MB, Haylock-Jacobs S, Cua R, Doring A, Sloka S, Stirling DP, Rivest S, Yong VW (2012) Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Annals of Neurology 72(3):419–432. doi:10.1002/ana.23599
Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, Pepinsky RB, Qiu M, Miller RH, Chan JR, Mi S (2007) NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 27(1):220–225. doi:10.1523/JNEUROSCI.4175-06.2007
Li H, Lu Y, Smith HK, Richardson WD (2007) Olig1 and Sox10 interact synergistically to drive myelin basic protein transcription in oligodendrocytes. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 27(52):14375–14382. doi:10.1523/jneurosci.4456-07.2007
Ligon KL, Fancy SP, Franklin RJ, Rowitch DH (2006) Olig gene function in CNS development and disease. Glia 54(1):1–10. doi:10.1002/glia.20273
Liu L, Darnall L, Hu T, Choi K, Lane TE, Ransohoff RM (2010) Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 30(27):9074–9083. doi:10.1523/jneurosci.1238-10.2010
Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Medicine 8(5):500–508. doi:10.1038/nm0502-500
Maire CL, Wegener A, Kerninon C, Nait Oumesmar B (2010) Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination. Stem Cells (Dayton, Ohio) 28 (9):1611-1622. doi:10.1002/stem.480
Manitt C, Kennedy TE (2002) Where the rubber meets the road: netrin expression and function in developing and adult nervous systems. Progress in Brain Research 137:425–442
Massey JM, Amps J, Viapiano MS, Matthews RT, Wagoner MR, Whitaker CM, Alilain W, Yonkof AL, Khalyfa A, Cooper NG, Silver J, Onifer SM (2008) Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Experimental Neurology 209(2):426–445. doi:10.1016/j.expneurol.2007.03.029
Mhaille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, FitzGerald U (2008) Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. Journal of neuropathology and Experimental Neurology 67(3):200–211. doi:10.1097/NEN.0b013e318165b239
Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Pepinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nature Medicine 13(10):1228–1233. doi:10.1038/nm1664
Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nature Neuroscience 7(3):221–228. doi:10.1038/nn1188
Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nature Neuroscience 8(6):745–751. doi:10.1038/nn1460
Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chedotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B (2009) Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Annals of Neurology 65(3):304–315. doi:10.1002/ana.21581
Miron VE, Kuhlmann T (1812) Antel JP (2011) Cells of the oligodendroglial lineage, myelination, and remyelination. Biochimica et Biophysica Acta 2:184–193. doi:10.1016/j.bbadis.2010.09.010
Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M, Newcombe J, Wekerle H, Hohlfeld R, Lassmann H, Meinl E (2010) Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathology (Zurich, Switzerland) 20 (5):966-975. doi:10.1111/j.1750-3639.2010.00399.x
Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Nait Oumesmar B (2013) SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Glia 61(10):1659–1672. doi:10.1002/glia.22547
Moreno S, Farioli-Vecchioli S, Ceru MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123(1):131–145
Moyon S, Dubessy AL, Aigrot MS, Trotter M, Huang JK, Dauphinot L, Potier MC, Kerninon C, Melik Parsadaniantz S, Franklin RJ, Lubetzki C (2015) Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 35(1):4–20. doi:10.1523/jneurosci.0849-14.2015
Mozafari S, Javan M, Sherafat MA, Mirnajafi-Zadeh J, Heibatollahi M, Pour-Beiranvand S, Tiraihi T, Ahmadiani A (2011) Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination: possible role for 3rd ventricle proliferating cells. Neuromolecular Medicine 13(2):138–150. doi:10.1007/s12017-011-8143-0
Mozafari S, Sherafat MA, Javan M, Mirnajafi-Zadeh J, Tiraihi T (2010) Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Research 1351:50–56. doi:10.1016/j.brainres.2010.07.026
Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ (2015) Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522(7555):216–220. doi:10.1038/nature14335
Napoli I, Neumann H (2010) Protective effects of microglia in multiple sclerosis. Experimental Neurology 225(1):24–28. doi:10.1016/j.expneurol.2009.04.024
Narayanan SP, Flores AI, Wang F, Macklin WB (2009) Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 29(21):6860–6870. doi:10.1523/jneurosci.0232-09.2009
Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes H-G, Rot A, Thelen M (2010) CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5(2):e9175
Nickles D, Chen HP, Li MM, Khankhanian P, Madireddy L, Caillier SJ, Santaniello A, Cree BA, Pelletier D, Hauser SL, Oksenberg JR, Baranzini SE (2013) Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. Human Molecular Genetics 22(20):4194–4205. doi:10.1093/hmg/ddt267
Omari KM, John GR, Sealfon SC, Raine CS (2005) CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain : A Journal of Neurology 128(Pt 5):1003–1015. doi:10.1093/brain/awh479
Omari KM, Lutz SE, Santambrogio L, Lira SA, Raine CS (2009) Neuroprotection and Remyelination after Autoimmune Demyelination in Mice that Inducibly Overexpress CXCL1. The American Journal of Pathology 174(1):164–176. doi:10.2353/ajpath.2009.080350
Patel JR, McCandless EE, Dorsey D, Klein RS (2010) CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proceedings of the National Academy of Sciences 107(24):11062–11067
Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, Klein RS (2012) Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta neuropathologica 124(6):847–860
Pendleton JC, Shamblott MJ, Gary DS, Belegu V, Hurtado A, Malone ML, McDonald JW (2013) Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPsigma. Experimental neurology 247:113–121. doi:10.1016/j.expneurol.2013.04.003
Piaton G, Aigrot MS, Williams A, Moyon S, Tepavcevic V, Moutkine I, Gras J, Matho KS, Schmitt A, Soellner H, Huber AB, Ravassard P, Lubetzki C (2011) Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain : A Journal of Neurology 134(Pt 4):1156–1167. doi:10.1093/brain/awr022
Pourabdolhossein F, Mozafari S, Morvan-Dubois G, Mirnajafi-Zadeh J, Lopez-Juarez A, Pierre-Simons J, Demeneix BA, Javan M (2014) Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm. PLoS One 9(9):e106378. doi:10.1371/journal.pone.0106378
Rajasekharan S, Bin JM, Antel JP, Kennedy TE (2010) A central role for RhoA during oligodendroglial maturation in the switch from netrin-1-mediated chemorepulsion to process elaboration. Journal of neurochemistry 113(6):1589–1597. doi:10.1111/j.1471-4159.2010.06717.x
Robinson S, Miller RH (1999) Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Developmental Biology 216(1):359–368. doi:10.1006/dbio.1999.9466
Rodgers JM, Robinson AP, Miller SD (2013) Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discovery Medicine 16(86):53–63
Seifert T, Bauer J, Weissert R, Fazekas F, Storch MK (2007) Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination. Acta Neuropathologica 113(2):195–203. doi:10.1007/s00401-006-0170-9
Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Baron Van Evercooren A, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U (2004) Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Molecular and Cellular Neurosciences 25(4):707–721. doi:10.1016/j.mcn.2003.12.014
Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casaccia-Bonnefil P (2008) Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nature Neuroscience 11(9):1024–1034. doi:10.1038/nn.2172
Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K (2005) Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Developmental Biology 282(2):397–410. doi:10.1016/j.ydbio.2005.03.020
Siebert JR, Osterhout DJ (2011) The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. Journal of Neurochemistry 119(1):176–188. doi:10.1111/j.1471-4159.2011.07370.x
Siebert JR, Stelzner DJ, Osterhout DJ (2011) Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells. Experimental Neurology 231(1):19–29. doi:10.1016/j.expneurol.2011.05.002
Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T (2010) Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proceedings of the National Academy of Sciences of the United States of America 107(25):11555–11560. doi:10.1073/pnas.1006496107
Spassky N, de Castro F, Le Bras B, Heydon K, Queraud-LeSaux F, Bloch-Gallego E, Chedotal A, Zalc B, Thomas JL (2002) Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 22(14):5992–6004.
Starkey ML, Bartus K, Barritt AW, Bradbury EJ (2012) Chondroitinase ABC promotes compensatory sprouting of the intact corticospinal tract and recovery of forelimb function following unilateral pyramidotomy in adult mice. The European Journal of Neuroscience 36(12):3665–3678. doi:10.1111/ejn.12017
Steinbach K, McDonald CL, Reindl M, Schweigreiter R, Bandtlow C, Martin R (2011) Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis. PLoS One 6(11):e26341. doi:10.1371/journal.pone.0026341
Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJ (2004) Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain : A Journal of Neurology 127(Pt 9):1928–1941. doi:10.1093/brain/awh217
Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Siskova Z, Maier O, Ffrench-Constant C, Franklin RJ, Hoekstra D, Zhao C, Baron W (2013) Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain : A Journal of Neurology 136(Pt 1):116–131. doi:10.1093/brain/aws313
Stolt CC, Lommes P, Friedrich RP, Wegner M (2004) Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy. Development (Cambridge, England) 131 (10):2349-2358. doi:10.1242/dev.01114
Stumm R, Kolodziej A, Schulz S, Kohtz JD, Hollt V (2007) Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. The Journal of Comparative Neurology 502(3):382–399. doi:10.1002/cne.21336
Sugimoto Y, Taniguchi M, Yagi T, Akagi Y, Nojyo Y, Tamamaki N (2001) Guidance of glial precursor cell migration by secreted cues in the developing optic nerve. Development (Cambridge, England) 128 (17):3321-3330
Sun JJ, Ren QG, Xu L, Zhang ZJ (2015) LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Scientific Reports. doi:10.1038/srep14235
Syed YA, Hand E, Mobius W, Zhao C, Hofer M, Nave KA, Kotter MR (2011) Inhibition of CNS remyelination by the presence of semaphorin 3A. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 31(10):3719–3728. doi:10.1523/jneurosci.4930-10.2011
Tepavcevic V, Kerninon C, Aigrot MS, Meppiel E, Mozafari S, Arnould-Laurent R, Ravassard P, Kennedy TE, Nait-Oumesmar B, Lubetzki C (2014) Early netrin-1 expression impairs central nervous system remyelination. Annals of Neurology 76(2):252–268. doi:10.1002/ana.24201
Tran JQ, Rana J, Barkhof F, Melamed I, Gevorkyan H, Wattjes MP, de Jong R, Brosofsky K, Ray S, Xu L, Zhao J, Parr E, Cadavid D (2014) Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. Neurology (R) Neuroimmunology & Neuroinflammation 1 (2):e18. doi:10.1212/nxi.0000000000000018
Tsai HH, Frost E, To V, Robinson S, Ffrench-Constant C, Geertman R, Ransohoff RM, Miller RH (2002) The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110(3):373–383
Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA (1998) Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21(1):63–75
Wheeler NA, Fuss B (2016) Extracellular cues influencing oligodendrocyte differentiation and (re)myelination. Experimental Neurology 283 (Pt B):512-530. doi:10.1016/j.expneurol. 2016.03.019
Williams A, Piaton G, Aigrot MS, Belhadi A, Theaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C (2007) Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain : A Journal of Neurology 130(Pt 10):2554–2565. doi:10.1093/brain/awm202
Woodruff RH, Franklin RJ (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25(3):216–228
Xing YL, Roth PT, Stratton JA, Chuang BH, Danne J, Ellis SL, Ng SW, Kilpatrick TJ, Merson TD (2014) Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 34(42):14128–14146. doi:10.1523/jneurosci.3491-13.2014
Yang Y, Liu Y, Wei P, Peng H, Winger R, Hussain RZ, Ben LH, Cravens PD, Gocke AR, Puttaparthi K, Racke MK, McTigue DM, Lovett-Racke AE (2010) Silencing Nogo-A promotes functional recovery in demyelinating disease. Annals of Neurology 67(4):498–507. doi:10.1002/ana.21935
Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, Rowitch DH, Raine CS, Brosnan CF, John GR (2009) Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proceedings of the National Academy of Sciences of the United States of America 106(45):19162–19167. doi:10.1073/pnas.0902834106
Zhao C, Fancy SP, ffrench-Constant C, Franklin RJ (2008) Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiology of Disease 31(2):209–217. doi:10.1016/j.nbd.2008.04.007
Zhao C, Li WW, Franklin RJ (2006) Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiology of Aging 27(9):1298–1307. doi:10.1016/j.neurobiolaging.2005.06.008
Zhou Q, Anderson DJ (2002) The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109(1):61–73
Acknowledgements
Authors are thankful to Tarbiat Modares University, Royan institute, and Iranian Science Foundation for their support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Motavaf, M., Sadeghizadeh, M. & Javan, M. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis. Cell Mol Neurobiol 37, 1335–1348 (2017). https://doi.org/10.1007/s10571-017-0472-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-017-0472-6